Clin Exp Vaccine Res.  2016 Jan;5(1):3-5. 10.7774/cevr.2016.5.1.3.

The prevention of pneumococcal infections

Affiliations
  • 1Department of Pathology, Seoul National University Boramae Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • 2Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. yeom3477@daum.net

Abstract

No abstract available.


MeSH Terms

Pneumococcal Infections*

Reference

1. Woo JH. Pneumonia and clinical understanding. Ulsan: University of Ulsan Press;1998. p. 53–62.
2. Woo JH, Kang JM, Kim YS, et al. A prospective multicenter study of community-acquired pneumonia in adults with emphasis on bacterial etiology. Korean J Infect Dis. 2001; 33:1–7.
3. Chong YP, Jung KS, Lee KH, et al. The bacterial etiology of community-acquired pneumonia in Korea: a nationwide prospective multicenter study. Infect Chemother. 2010; 42:397–403.
Article
4. Causes of Death Statistics in 2014 [Internet]. Daejeon: Statistics Korea;2015. cited 2015 Nov 1. Available from: http://kostat.go.kr.
5. Kim SH, Woo JH. Pneumococcal vaccine. Hanyang Med Rev. 2008; 28(3):52–57.
6. Korean Society of Infectious Diseases. Adult vaccination. Seoul: Koonja Publishing Co.;2007. p. 26–34.
7. Woo JH. Pnemococcal vaccination. Infect Chemother. 2005; 37:Suppl 1. S3–S5.
8. Vila-Corcoles A, Ochoa-Gondar O. Preventing pneumococcal disease in the elderly: recent advances in vaccines and implications for clinical practice. Drugs Aging. 2013; 30:263–276.
9. Aliberti S, Mantero M, Mirsaeidi M, Blasi F. The role of vaccination in preventing pneumococcal disease in adults. Clin Microbiol Infect. 2014; 20:Suppl 5. 52–58.
Article
10. Yong S, Shin GC. Immunological effects of pneumococcal vaccine in older adults. Korean J Infect Dis. 1995; 27:157–166.
11. Chang SH, Lee HJ, Shin HY, Ahn HS, Choi Y. Immunogenicity and safety of 23-valent pnemococcal polysaccharide vaccine among high-risk and healthy children. Korean J Infect Dis. 1994; 26:217–227.
12. Lee H, Choi EH, Lee HJ. Efficacy and effectiveness of extended-valency pneumococcal conjugate vaccines. Korean J Pediatr. 2014; 57:55–66.
Article
13. Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine. Vaccine. 2011; 29:9127–9131.
Article
14. Kim KH, Hong JY, Lee H, et al. Nasopharyngeal pneumococcal carriage of children attending day care centers in Korea: comparison between children immunized with 7-valent pneumococcal conjugate vaccine and non-immunized. J Korean Med Sci. 2011; 26:184–190.
Article
15. Cho EY, Kang HM, Lee J, Kang JH, Choi EH, Lee HJ. Changes in serotype distribution and antibiotic resistance of nasopharyngeal isolates of Streptococcus pneumoniae from children in Korea, after optional use of the 7-valent conjugate vaccine. J Korean Med Sci. 2012; 27:716–722.
Article
16. Ben-Shimol S, Givon-Lavi N, Greenberg D, Dagan R. Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel. Hum Vaccin Immunother. 2015; 10. 02. [Epub]. DOI: 10.1080/21645515.2015.1095414.
17. Dagan R, Patterson S, Juergens C, et al. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial. Clin Infect Dis. 2013; 57:952–962.
Article
18. Kaplan SL, Barson WJ, Lin PL, et al. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2013; 32:203–207.
Article
19. Cho EY, Lee H, Choi EH, et al. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolated from invasive infections after optional use of the 7-valent conjugate vaccine in Korea, 2006-2010. Diagn Microbiol Infect Dis. 2014; 78:481–486.
Article
20. Choi EH, Kim SH, Eun BW, et al. Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis. 2008; 14:275–281.
Full Text Links
  • CEVR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr